FDA 483 - Capzer Pharmaceuticals - July 24, 2025

Capzer Pharmaceuticals, a control laboratory in Lake Worth Beach, FL, was inspected by the FDA, revealing significant deficiencies. The inspection found that the firm's quality control unit lacked adequately written and followed procedures, and laboratory records were incomplete, specifically missing sample collection dates. These issues indicate a failure to adhere to established quality standards for pharmaceutical operations.